AB
Insider
Andrew Scott Blank
DirectorAndrew Scott Blank (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in BCDA. Across 1 priced purchase filing, the average 21-session return was +20.8% from execution and +27.4% from disclosure (delay-adjusted; derived). The median gap between execution and disclosure was 4 days.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+20.8%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+27.4%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
4d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
–
no filings in the window
Last traded
Sep 19 2025
Filed Sep 23 2025
Volume by month
Buys $761K
Sells $0
Shares × price, as filed · by filing month · past 24 months
Most traded names
BCDA
BCDA
BCDA · 3 buys · 0 sells
3 filings
Recent filings
BCDAPURCHASE
BioCardia, Inc.
View filing →
$360K288,000 sh × $1.25
Exec Sep 19 2025
Filed Sep 23 2025 · 9:00 AM ET BCDAPURCHASE BioCardia, Inc. View filing → $150K
72,289 sh × $2.08
Exec Jun 30 2025
Filed Jul 2 2025 · 5:30 PM ET BCDAPURCHASE BioCardia, Inc. View filing → $251K
131,233 sh × $1.91
Exec Apr 23 2025
Filed Apr 25 2025 · 5:30 PM ET